Related Experiment Video

Updated: Jun 22, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B

Romuald Bellmann1, John D Cleary, Jaroslav Sterba

  • 1Division of General Internal Medicine Intensive Care Unit and Inflammation Innsbruck Medical School Department of Internal Medicine, Innsbruck, Austria

Clinical Advances in Hematology & Oncology : H&O
|June 20, 2009
PubMed

Insights

Lipid formulations of Amphotericin B offer improved safety profiles for treating invasive fungal infections. This review compares their pharmacokinetics, efficacy, and safety, aiding clinical decisions in high-risk patients.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Invasive fungal infections pose significant risks, particularly in critically ill and immunocompromised individuals.
  • Amphotericin B is a primary treatment but is limited by poor solubility and dose-related toxicities, notably nephrotoxicity.
  • Lipid-based formulations of Amphotericin B have been developed to mitigate these limitations.

Purpose of the Study:

  • To compare pharmacokinetic, efficacy, and safety data of available lipid-based Amphotericin B formulations.
  • To evaluate these formulations across diverse patient populations.
  • To describe infusion-related reactions and propose a prevention algorithm.

Main Methods:

  • Comparative review of existing pharmacokinetic, efficacy, and safety data.
  • Analysis of studies involving different lipid formulations of Amphotericin B.
  • Literature search for infusion-related reactions and premedication strategies.

Main Results:

  • Lipid formulations demonstrate varied pharmacokinetic profiles and clinical efficacy.
  • Safety data indicate reduced nephrotoxicity compared to conventional Amphotericin B.
  • Infusion-related reactions are associated with specific formulation characteristics and administration methods.

Conclusions:

  • Lipid-based Amphotericin B formulations represent a safer alternative for systemic fungal infections.
  • Understanding formulation-specific data is crucial for optimizing treatment in vulnerable patient groups.
  • A structured approach to premedication can minimize infusion-related adverse events.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...